Nomura upgraded Raffles Medical Group to Buy from Neutral with an unchanged price target of S$1.60. The analyst sees the company benefiting from an increase in local and foreign patients in its Singapore hospitals.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>